These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19478510)

  • 1. Interim monitoring of clinical trials.
    Richardson D
    Front Neurol Neurosci; 2009; 25():127-130. PubMed ID: 19478510
    [No Abstract]   [Full Text] [Related]  

  • 2. Pursuit of truly independent data monitoring committees in research.
    Marston L; McKenzie DR; Freemantle N
    BMJ; 2016 May; 353():i2309. PubMed ID: 27172924
    [No Abstract]   [Full Text] [Related]  

  • 3. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials.
    Anderson JR; Krailo M
    Am J Bioeth; 2011 Mar; 11(3):18-9. PubMed ID: 21400379
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of the Consolidated Standards of Reporting Trials (CONSORT) in the Fracture Care Literature.
    Bhandari M; Guyatt GH; Lochner H; Sprague S; Tornetta P
    J Bone Joint Surg Am; 2002 Mar; 84(3):485-9. PubMed ID: 11886922
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.
    Hemmings R; Day S
    Drug Saf; 2004; 27(1):1-6. PubMed ID: 14720083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies.
    Turnbull BW
    Clin Trials; 2017 Oct; 14(5):462-469. PubMed ID: 28178849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethics and evidence in clinical trials.
    Goodman SN
    Clin Trials; 2005; 2(3):195-6. PubMed ID: 16279142
    [No Abstract]   [Full Text] [Related]  

  • 11. Reporting standards for adverse events after medical device use in the peripheral vascular system.
    Ouriel K; Fowl RJ; Davies MG; Forbes TL; Gambhir RP; Morales JP; Ricci MA;
    J Vasc Surg; 2013 Sep; 58(3):776-86. PubMed ID: 23972246
    [No Abstract]   [Full Text] [Related]  

  • 12. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees.
    Wells RJ; Gartside PS; McHenry CL
    IRB; 2000 Jan; 22(1):7-11. PubMed ID: 12546010
    [No Abstract]   [Full Text] [Related]  

  • 14. When should data and safety monitoring committees share interim results in cardiovascular trials?
    Borer JS; Gordon DJ; Geller NL
    JAMA; 2008 Apr; 299(14):1710-2. PubMed ID: 18398083
    [No Abstract]   [Full Text] [Related]  

  • 15. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks in Randomized Controlled Trials: Role of Interim Analysis and Data Monitoring Committee.
    Naqvi HA
    J Coll Physicians Surg Pak; 2015 Aug; 25(8):557-9. PubMed ID: 26305298
    [No Abstract]   [Full Text] [Related]  

  • 17. Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.
    Korn EL; Freidlin B
    Am J Bioeth; 2011 Mar; 11(3):2-10. PubMed ID: 21400374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from recent cardiovascular clinical trials: Part II.
    DeMets DL; Califf RM
    Circulation; 2002 Aug; 106(7):880-6. PubMed ID: 12176964
    [No Abstract]   [Full Text] [Related]  

  • 19. Data Safety Monitoring Board (DSMB).
    Welch KM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():46-7. PubMed ID: 15512871
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.